See a compilation of latest industry news below. The links to the original article are within each post

BRIEF-Dova Pharmaceuticals Announces US FDA Approval Of Doptelet

May 21 (Reuters) – Dova Pharmaceuticals Inc: * DOVA PHARMACEUTICALS ANNOUNCES U.S. FDA APPROVAL OF DOPTELET® (AVATROMBOPAG) * DOVA PHARMACEUTICALS INC – POSITIONED TO LAUNCH DOPTELET IN JUNE Source text for Eikon: Further company coverage: Our Standards:The Thomson Reuters Trust Principles. This article was originally posted elsewhere. Link to original article.

Glenmark Pharmaceuticals Announces the Company's First New Drug Application for Ryaltris™ for …

MAHWAH, N.J., May 21, 2018 /PRNewswire/ — Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for its leading respiratory pipeline candidate Ryaltris™ (rye – al’ – tris), an investigational fixed-dose combination nasal spray of an antihistamine and

Should The FDA Be Shaming Drug Companies? Financial Advisors' Daily Digest

Last Thursday the FDA published a name-and-shame list of brand-name drug makers that may be withholding access to samples that competing drug makers could use to have generic versions available for use when the original manufacturer’s patent expires. Celgene (NASDAQ:CELG), Johnson & Johnson’s (NYSE:JNJ) Actelion unit, Novartis (NYSE:NVS) and Gilead Sciences (NASDAQ:GILD) top the list